![Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors]()
Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitorsOrtiz-Cuaran, S.; Scheffler, M.; Plenker, D.; Dahmen, I.; Scheel, A.; Fernandez-Cuesta, L.; Meder, L.; Lovly, C. M.; Persigehl, T.; Merkelbach-Bruse, S.; Bos, M.; Michels, S.; Fischer, R.; Albus, K.; Ko nig, K.; Schildhaus, H.-U.; Fassunke, J.; Ihle, M. A.; Pasternack, H.; Heydt, C.; Becker, C.; Altmu ller, J.; Ji, H.; Mu ller, C.; Florin, A.; Heuckmann, J. M.; Nuernberg, P.; Ansen, S.; Heukamp, L. C.; Berg, J.; Pao, W.; Peifer, M.; Bu ttner, R.; Wolf, J.; Thomas, R. K.; Sos, M. L. · Clinical Cancer Research · 2016